Extraordinary General Meeting of Agfa-Gevaert NV - regulated information
March 11 2025 - 11:40AM
UK Regulatory
Extraordinary General Meeting of Agfa-Gevaert NV - regulated
information
March 11, 2025 – 5.40 PM CET
Regulated information
Extraordinary General Meeting of Agfa-Gevaert
NV
Mortsel, Belgium – March 11, 2025 – 5.40 p.m.
CET
On Tuesday, March 11, Agfa held an Extraordinary General Meeting at
its head office in Mortsel, Belgium.
At the meeting, the shareholders approved the reduction of the
capital of the Company to the amount of 26,000,000.00 euro by
offsetting losses incurred in the amount of 160,794,611.00
euro.
Also approved were clarifications in the articles of association
regarding the authorized capital, share buybacks, conflicts of
interest and statutory auditor supervision as well as adaptations
to the articles of association to reflect legislative changes with
regard to independent directors and Group internal conflicts of
interest.
The shareholders also agreed with additions to the articles of
association with regard to the variable remuneration of executive
directors and of day-to-day management.
The minutes of the Extraordinary General Meeting will be
published on the Special and Extraordinary General Meetings page of
the agfa.com website.
(end of message)
About Agfa-Gevaert
The Agfa-Gevaert Group is a leading company in imaging technology
and IT solutions with over 150 years of experience. The Group holds
three divisions: Radiology Solutions, HealthCare IT and Digital
Print & Chemicals. They develop, manufacture and market
analogue and digital systems for the healthcare sector, for
specific industrial applications and for the printing industry. In
2023, the Group realized a turnover of 1,150 million euro.
www.agfa.com
Contact:
Viviane Dictus
Director Corporate Communications
tel. +32 0 3 444 7124
e-mail: viviane.dictus@agfa.com
AGFA Gevaert NV (EU:AGFB)
Historical Stock Chart
From Feb 2025 to Mar 2025
AGFA Gevaert NV (EU:AGFB)
Historical Stock Chart
From Mar 2024 to Mar 2025
